Search Within

Michael Morris

  1. "Yu Chen"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (19)
  2. GSK Faculty (19)
  3. Genitourinary Oncology Service (19)
  4. Human Oncology and Pathogenesis Program (19)
  5. Solid Tumor Oncology Division (19)
  6. Hematologic Malignancies, Division of (16)

More Groups

People
  1. Yu Chen (19)
  2. Howard Scher (13)
  3. Charles Sawyers (10)
  4. Dana Rathkopf (10)
  5. Susan Slovin (9)
  6. Anuradha Gopalan (8)

More People

Years
  1. 2025 (2)
  2. 2023 (2)
  3. 2022 (5)
  4. 2020 (1)
  5. 2018 (1)
  6. 2017 (2)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cell (2)
  3. Clinical Cancer Research (1)
  4. European Journal of Cancer (1)
  5. European Urology (1)
  6. European Urology Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (8)
  2. Cell Press (2)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. American Association for the Advancement of Science (1)
  6. Elsevier BV (1)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b/2 study evaluating the activity of tinengotinib in combination with androgen receptor pathway inhibitors (ARPIs) in patients with metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Abida, W.; Chen, Y.; McHugh, D. J.; Morris, M. J.; Wu, F.; Peng, P.; Hennessy, K.; Wang, H.; Fan, J.; Zaidi, S.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical, imaging, and technical factors associated with successful genomic profiling of bone biopsy tissue in prostate cancer
    Journal Article

    Ridouani, F.; Vargas, H. A.; Holzwanger, D. J.; Schöder, H.; Waters, E.; Petre, E. N.; Martin, A.; Satagopan, J.; Gonen, M.; Autio, K. A.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer
    Meeting Abstract

    Zaidi, S.; Chan, J. M.; Love, J.; Zhao, J.; Setty, M.; Lawrence, K.; Gopalan, A.; Goodrich, D.; Morris, M. J.; Chen, Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Lineage plasticity in prostate cancer depends on FGFR and JAK/STAT inflammatory signaling
    Meeting Abstract

    Chan, J.; Zaidi, S.; Love, J.; Zhao, J.; Setty, M.; Wadosky, K.; Gopalan, A.; Choo, Z. N.; Persad, S.; Chaudhary, O.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Molecular imaging of neuroendocrine prostate cancer by targeting delta-like ligand 3
    Journal Article

    Korsen, J. A.; Kalidindi, T. M.; Khitrov, S.; Samuels, Z. V.; Chakraborty, G.; Gutierrez, J. A.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
    Journal Article

    Chan, J. M.; Zaidi, S.; Love, J. R.; Zhao, J. L.; Setty, M.; Wadosky, K. M.; Gopalan, A.; Choo, Z. N.; Persad, S.; Choi, J.; more...
    Science (2022)

    Fulltext@MSK | Save
  • Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
    Journal Article

    Korsen, J. A.; Gutierrez, J. A.; Tully, K. M.; Carter, L. M.; Samuels, Z. V.; Khitrov, S.; Poirier, J. T.; Rudin, C. M.; Chen, Y.; Morris, M. J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Dickkopf-1 can lead to immune evasion in metastatic castration-resistant prostate cancer
    Journal Article

    Wise, D. R.; Schneider, J. A.; Armenia, J.; Febles, V. A.; McLaughlin, B.; Brennan, R.; Thoren, K. L.; Abida, W.; Sfanos, K. S.; De Marzo, A. M.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save